Median Technologies has welcomed Didric Cederholm to its Board of Directors.

Cederholm is a founding partner and chief investment officer of Lion Point Capital, a global special situations investment fund. Before founding Lion Point Capital, Cederholm spent nearly eight years at Elliott Management and was previously a principal at Eos Partners. 

“We are thrilled to welcome Didric Cederholm to our Board of Directors. Didric’s deep understanding of global markets and entrepreneurial mindset will be invaluable as we continue to accelerate our growth and deliver long-term value to our stakeholders,” Median Technologies Founder/CEO Fredrik Brag said. “As founding partner of Lion Point Capital, he brings a wealth of experience in strategic investing and value creation and joins Median at a pivotal moment, as we move towards the major milestone of potential market authorization in the United States for eyonis LCS. Didric’s expertise ideally complements the diverse and highly experienced perspectives already represented on our board, strengthening our ability to navigate this transformative phase with confidence and ambition with deep-seated knowledge and expertise embedded throughout the company.” 

Cederholm graduated in 2003 with honors from Columbia Business School, where he was a Fulbright Scholar, and has a LLM from Stockholm University, where he graduated in 2001. From 1997-1999, Cederholm served in the Swedish Armed Forces as an interrogation officer and later as a 2nd Lieutenant in Swedish Military Intelligence. He lives in New York City with his wife Kristin, and their four children.

“I’m honored to join Median’s board at this important moment. The company has made clear progress on its FDA pathway and commercial preparation for eyonis LCS, and I look forward to working with Fredrik, Oran, the management team and my fellow directors to help accelerate execution and build long-term value for patients and shareholders,” Cederholm stated.

Lion Point Capital LP is a global investment firm that invests in equity and debt securities of undervalued public and private companies. Its partners have extensive experience and a successful track record of uncovering and unlocking value through rigorous fundamental analysis and thoughtful actions, encompassing strategy changes, operational efficiency improvements and governance enhancements. Lion Point was founded in 2014.

Pioneering software as a medical device and imaging services, Median Technologies harnesses cutting-edge artificial intelligence (AI) to enhance the accuracy of early cancer diagnoses and treatments. Median’s offerings include iCRO, which provides medical image analysis and management in oncology trials, and eyonis, an AI/ML tech-based suite of software as a medical device (SaMD). The French company, with a presence in the United States and China, trades on the Euronext Growth market.